(Q34271952)

1 August 2017

1 reference

title

Medical therapy for acute ischemic stroke (English)

1 reference

1 August 2017

Goldstein LB

1

1 reference

1 August 2017

1 July 2001

1 reference

Current Atherosclerosis Reports

1 August 2017

1 reference

1 August 2017

3

1 reference

1 August 2017

4

1 reference

1 August 2017

299-306

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-001-0023-x

1 August 2017

0 references

cites work

Tissue-type plasminogen activator should not be used in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Early hemorrhage growth in patients with intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

What role do neurologists play in determining the costs and outcomes of stroke patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Early intravenous thrombolysis for acute ischemic stroke in a community-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Intra-arterial thrombolysis for perioperative stroke after open heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Effects of a specialized team on stroke care. The first two years of the Yale Stroke Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Effect of a stroke protocol on hospital costs of stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Fever in acute stroke worsens prognosis. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

The cerebral collateral circulation. I. Factors influencing collateral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Acute hypertension after stroke: the scientific basis for treatment decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-001-0023-X

Hazards of therapy for excessive hypertension in acute stroke

21 January 2018

1 reference

12 December 2020

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

12 December 2020

North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke

1 reference

12 December 2020

Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

1 reference

12 December 2020

Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial

1 reference

12 December 2020

Hypothermia as a potential treatment for cerebral ischemia

1 reference

12 December 2020

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study

1 reference

12 December 2020

Very high blood pressure in acute stroke.

1 reference

12 December 2020

Selective intra-arterial fibrinolysis of acute central retinal artery occlusion

1 reference

12 December 2020

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

1 reference

12 December 2020

Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

1 reference

12 December 2020

Management of stroke complicating cardiac catheterization with recombinant tissue-type plasminogen activator

1 reference

12 December 2020

Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome

1 reference

12 December 2020

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

12 December 2020

How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke Unit Trialists Collaboration

1 reference

12 December 2020

Potential effects of common drugs on stroke recovery.

1 reference

12 December 2020

A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke St

1 reference

12 December 2020

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke

1 reference

12 December 2020

Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness

1 reference

12 December 2020

Benign prognosis of never-symptomatic carotid occlusion

1 reference

12 December 2020

Thrombolytic therapy in acute ischaemic stroke: the jury needs more evidence

1 reference

12 December 2020

Practice advisory: thrombolytic therapy for acute ischemic stroke--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group

1 reference

12 December 2020

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

1 reference

12 December 2020

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study

1 reference

12 December 2020

Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience

1 reference

12 December 2020

Blood Pressure After Stroke

1 reference

12 December 2020

Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke.

1 reference

12 December 2020

Thrombolysis for stroke

1 reference

12 December 2020

The importance of brain temperature in cerebral ischemic injury

1 reference

12 December 2020

Treating ischemic stroke as an emergency.

1 reference

12 December 2020

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial

1 reference

12 December 2020

Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction.

1 reference

12 December 2020

Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease

1 reference

12 December 2020

Impaired neurogenic cerebrovascular control and dysautoregulation after stroke

1 reference

12 December 2020

Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches

1 reference

12 December 2020

Thrombolytic therapy with streptokinase in acute ischemic stroke.

1 reference

12 December 2020

The influence of hyperglycemia on outcome of cerebral infarction

1 reference

12 December 2020

Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA)

1 reference

12 December 2020

["Drop hand" resulting from cerebral infarction--case report]

1 reference

12 December 2020

Implementation of an acute stroke program decreases hospitalization costs and length of stay

1 reference

12 December 2020

Saline contrast and colour Doppler transoesophageal echocardiography in detecting a patent foramen ovale and right-to-left shunts in stroke patients

1 reference

12 December 2020

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group

1 reference

12 December 2020

10.1007/S11883-001-0023-X

Identifiers

DOI

1 reference

PubMed ID

11389795

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11389795